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Background: Lymphoscintigraphy has largely been performed to diagnose lymphedema. It is, however a time-consuming
and expensive technique, which has not been covered by Japanese medical insurance since the year 2002. In this report we
introduce a new imaging technique of fluorescent lymphography to diagnose lymphedema.
Methods: Fluorescence images of subcutaneous lymphatic drainage after subcutaneous injection of indocyanine green
(ICG) at the foot were obtained using a newly developed near-infrared camera system. ICG fluorescent lymphography
was performed in 12 patients with secondary lymphedema and 10 healthy volunteers. The 12 patients were diagnosed
with secondary lymphedema according to the medical history and lymphoscintigram, of which 11 had a history of
hysterectomy with extended lymph node dissection and local radiation therapy for uterine cancer. Lymphedema
developed in one patient after femorotibial artery bypass for peripheral artery occlusive disease.
Results: Four abnormal fluorescent patterns of the lymph drainage were observed in lymphedema: dermal backflow (an
abnormal filling of the lymph capillaries), extended fluorescent signal at the dorsum and plantar region of the foot, dilated
lymph channels with proximal obliteration, and diffuse glittering of fluorescent signals with scattered twinkling of the
dye. Continuous lymph channels from the injection site of the foot to the groin were observed along the medial aspect of
thigh in healthy subjects.
Conclusion: ICG fluorescence lymphography is safe, simple, andminimally invasive. The device is portable and easy to use.
The technique may be useful in clinical practice to identify presence of lymphatic disorder. ( J Vasc Surg 2007;45:
1016-21.)Evaluation and diagnosis of the swollen extremity re-
mains a challenge. The diagnosis of extremity swelling can
frequently be established by a careful history and physical
examination. Among the etiologies, lymphedema is one of
the common diseases to be differentiated from other types
of edema. Skin thickening and hyperkeratosis develop in
the advanced form of lymphedema; however, an imaging
modality is needed to establish the diagnosis because the
clinical findings in the early stage of lymphedema may not
be indistinguishable from other forms of edema.
Among the imaging modalities, direct contrast lym-
phography accurately visualizes the lymphatics and contrib-
utes to the diagnosis of lymphedema1-3; however, the
tedious operative procedure to expose foot lymph as well as
complications from the contrast agent have prevented
widespread use of this procedure in clinical practice.4,5 At
present, lymphoscintigraphy is considered a major imaging
modality for the diagnosis of patients with lymphedema
and for evaluation of the swollen extremity.6,7 It is, how-
ever, time consuming, expensive, and potentially teratoge-
netic during pregnancy. In particular, the cost of lympho-
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Although other diagnostic modalities such as magnetic
resonance imaging,8 computed tomography,9 or ultra-
sound images show characteristic features related to the
skin changes associated with lymphedema,10 they can only
suggest abnormalities of the lymphatics. The difficulty in
diagnosing lymphedema prompted us to explore a new
modality to diagnose lymphedema. In this article, we de-
scribe our preliminary experience with a novel imaging
technique that uses fluorescence of indocyanine green
(ICG) for the diagnosis of lymphedema of the lower ex-
tremity.
PATIENTS AND METHODS
Between March 1 and September 7, 2006, 16 extrem-
ities in 12 individuals (11 women, 1 man) with secondary
lymphedema underwent ICG lymphography at our depart-
ment. The subjects were 64.3  13.6 years old (range, 38
to 86 years). Eight patients had unilateral involvement, and
four had bilateral involvement. Ten healthy volunteers (7
men, 3 women; 44.9  17.3 years old) without any leg
symptoms were also examined as a control study.
Each patient with secondary lymphedema had previ-
ously undergone a physical examination, lymphoscintigra-
phy, and a duplex ultrasound study of the venous system of
the lower extremities to check for the venous insufficiency.
Amedical history had also been obtained from each patient.
The 11 women had a history of hysterectomy with ex-
tended lymph node dissection and local radiation therapy
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surgery. The male patient complained of leg edema after
femorotibial artery bypass for peripheral artery occlusive
disease.
All patients were diagnosed as having secondary
lymphedema by medical history or lymphoscintigram.
Among them, seven patients were previously diagnosed by
other physicians according to medical history and lym-
phoscintigram. Five patients in this study underwent lym-
phoscintigram to confirm the lymphatic disorder. None of
the healthy volunteers underwent lymphoscintigram under
the study protocol.
All patients showed leg edema at the time of investiga-
tion. The 11 patients with hysterectomy and radiation
underwent only compression therapy after manifestation of
leg swelling. Seven of the 11 women were at clinical stage II,
and the remaining four patients were at stage III.11 The
male patient had been treated with compression and mas-
sage therapy after bypass surgery for peripheral arterial
disease and was classed as stage I.
Fluorescence lymphography. With approval of the
ethical committee and written informed consent, fluores-
cence micrography was performed. A 27-gauge needle was
used to subcutaneously inject 0.2 mL of indocyanine green
(ICG; Diagnogreen 0.5%; Daiichi Pharmaceutical, Tokyo,
Japan) at the dorsum of the foot. The patient was asked to
stand immediately after the injection. After that, no stan-
dard exercises were prescribed as in lymphoscintigram.
Fluorescence images of the subcutaneous lymphatic
drainage were obtained using a newly developed near-
Fig 1. A, The device used in this study. The image can
images were recorded on the hard disk. B, Acquisition
instrument is equipped with a charge-coupled device cambe observed at the monitor of the laptop computer, and the
of images of fluorescent lymphography at the bedside. Theinfrared camera system (PDE; Hamamatsu Photonics K.K.Fig 2. A and B, Normal fluorescent lymphography in healthy vol-
unteers. Panoramic image shows continuous lymph channels from the
injection site at the foot to the groin along the medial aspect of thigh.
t sign
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at a wavelength of 760 nm and filters out light with a
wavelength below 820 nm. The light source was a light-
emitting diode (LED), and the detector was a charge-
coupled device (CCD) camera. The instrument is portable
and handy to use.
The fluorescence images were continuously observed
on the monitor of a laptop computer (LaVie G, Type T;
NEC Co., Tokyo, Japan; Fig 1, A). The video images of the
lymphatic drainage were converted digitally into AVI or
MPEG2 formatted data and recorded on the hard disk of
the computer. The movie files were later processed to still
panoramic pictures that showed the whole limb by using
Mofix image processing software (Emaki Inc, Aizuwaka-
matsu, Japan).
Image interpretation. A physician who did not know
the clinical diagnosis of the patients performed the ICG
fluorescence lymphography and interpreted the findings of
the real-time video images of subcutaneous lymphatic
drainage for the primary physician who was aware of the
patients’ past medical history and clinical diagnosis. The
video images were later converted to panoramic images by
image processing software by other physicians who had no
information about the patients. These images were retro-
spectively interpreted by yet another physician.
RESULTS
All fluorescent lymphography was successfully per-
Fig 3. Characteristic pattern of fluorescent lymphogr
backflow.B, Extended fluorescent images at the dorsum
proximal obliteration. D, Diffuse glittering of fluorescenformed without any complications. Visual interpretation ofthe image patterns demonstrated a distinct normal pattern
and several abnormal patterns. In healthy volunteers, the
normal fluorescence lymphographic pattern of the superfi-
cial lymphatic system of the lower extremities shows con-
tinuous lymph channels from the injection site on the foot
to the groin along the medial aspect of thigh (Fig 2). All 20
extremities from the healthy volunteer group showed a
similar normal pattern.
As shown in Fig 3 (A to D), four abnormal patterns of
lymph drainage were seen in patients with secondary
lymphedema: (A) fluorescent dermal backflow, which may
be an abnormal filling of the lymph capillaries; (B) ex-
tended fluorescent images at the dorsum and plantar region
of the foot, (C) dilated lymph channels with proximal
obliteration, and (D) diffuse glittering of fluorescent sig-
nals with scattered twinkling of the dye like the Milky Way.
In patients with secondary lymphedema, 15 of 16
swollen legs showed dermal backflow that is regarded as
lymphatic flow obliteration. Extensive spreading of the
fluorescent dye beyond the dorsum of the foot was also
found in all swollen legs. Proximal obliteration of lymph
vessels with dilated lymph vessels was found in eight of 16
legs. Six of 16 swollen legs showed diffuse glittering of
fluorescent signals with scattered twinkling of the dye like
the Milky Way. These image patterns were reproducibly
interpreted by the three different physicians.
The lymphoscintigram showed typical findings of
lymphedema in all 12 patients with secondary lymphed-
in patients with secondary lymphedema. A, Dermal
lantar region of the foot.C,Dilated lymph channels with
als with scattered twinkling of the dye.aphy
and pema, such as slow removal of the tracer from the injection
d pla
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Panoramic images covering the whole leg showed a com-
bination of abnormal findings of fluorescent staining and
facilitated understanding of the disease (Fig 4 and 5). The
image demonstrated the distribution of abnormal lymphat-
ics extending throughout the whole leg, and the combina-
tion of dermal backflow, extended fluorescent signals at the
dorsum of foot, or Milky Way sign were observed.
DISCUSSION
Isotope lymphoscintigraphy has been widely used to
diagnose lymph stasis and resultant lymphedema. Because
the technique is minimally invasive and can be performed
without discomfort, lymphoscintigraphy has replaced di-
rect contrast lymphography. The lymphoscintigram is an
expensive and time-consuming procedure, however, and
the technique has only been performed on selected patients
in clinical practice. Without a lymphoscintigram, physicians
must establish the diagnosis of lymphedema purely from
Fig 4. A, A 70-year-old woman with right lower extrem
node dissection, and pelvic radiotherapy for uterine can
shows extensive dermal pattern in the right leg. C, Indoc
backflow, extended fluorescent images at the dorsum anclinical criteria; therefore, a new diagnostic modality toexamine patients with swollen extremities is needed in
clinical practice that is effective and can be performed
without discomfort to patients. In particular, the technique
should be safe. To achieve these goals, we focused on ICG
fluorescence lymphography.
Fluorescence lymphography was first performed in hu-
man skin by Bollinger et al12 after injection of fluorescein
isothiocyanate (FITC)-dextran.12 By videomicroscopy, flu-
orescence microlymphography visualized the superficial
dermal network of lymphatic capillaries. The technique was
applied to patients with primary lymphedema and identified
the larger spreading of the injected fluorescent dye in the
superficial lymphatic capillary network.13 All of the previ-
ous methods of fluorescence lymphography have used
FITC-dextran to visualize microlymph vessels. Although
fluorescence microlymphography is useful to understand
changes in lymphatic capillaries and the intravital anatomy
of cutaneous lymphatic microvessels in a localized area,14 it
is not suitable for screening lymphedema and has failed to
mphedema who underwent hysterectomy, bilateral iliac
years earlier (clinical stage III). B, Lymphoscintigram
e green fluorescence lymphogram shows diffuse dermal
ntar region of the right foot, and Milky Way sign.ity ly
cer 30
yaninenter clinical practice to date.
hogr
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cence lymphography for diagnosing lymphedema. With
our technique, real-time imaging of lymphatic drainage of
the whole leg was obtained without patient discomfort.
The instrument to acquire images is equipped with an LED
and CCD camera and is very portable and handy to use.
During the examination, the patients can simultaneously
observe their video images together with the physician on a
monitor of a laptop computer.
ICG is a very safe compound that has been very widely
used in a variety of clinical situations, such as examination
of hepatic function, cardiac output, and retinal angiogra-
phy. It absorbs light in the near-infrared range, with a
maximum at 805 nm. The excitation wavelength of ICG
that produces the maximum fluorescence is 765 nm. ICG
fluorescences with a maximum at 840 nm in plasma.15 The
fluorescence of ICG in the near-infrared wavelength can
deeply penetrate living tissue and is advantageous for ob-
taining visual information. The use of ICG fluorescence has
previously been reported for diagnosing burn depth,16
evaluation of skin-flap viability,17 and intraoperative evalu-
ation of bypass graft patency.18
A previous study reported that fluorescence was ob-
served from ICG solution embedded 1 cm deep in material
with optical properties compatible with human tissue.19 In
Fig 5. A, A 69-year-old woman with left lower extrem
dissection and pelvic radiotherapy for uterine cancer 12
markedly delayed transport with dermal pattern in the
inguinal region. C, Indocyanine green fluorescence lympsubcutaneous tissue, most of ICG binds to albumin, whichis drained to the lymphatic vessels. These properties of ICG
have been used to detect sentinel nodes by fluorescence
navigation in breast cancer patients.19,20
We focused on ICG as a method for visualizing lymph
vessels. To our knowledge, this is the first report of ICG
fluorescent lymphography of lymphedema. In this study, in-
jecteddye to thedorsumof the foot drained to the groin along
the medial aspect of the thigh within 30 minutes in healthy
volunteers. In patients with lymphedema, however, several
characteristic images such as dermal back flow, obstructed
fluorescence images with dilatation and tortuosity, and Milky
Way sign were obtained. In particular, dermal backflow was
always observed in patients with secondary lymphedema, in-
dicating that this technique may be a better screening test to
identify the presence or absence of lymphatic disorder.
Further study is needed to determine whether fluores-
cence imageswith dilatation and tortuosity represent proximal
obstructive lymphatics with distal dilation. If this is confirmed,
the signmay facilitate patient selection for surgical procedures
such as lymph-venous anastomosis. The other abnormal pat-
ternMilkyWay sign, identified by diffuse glittering of fluores-
cent signalswith scattered twinkling of the dye,may reflect the
extended destruction of lymphatic channels. If this is true, the
patients with the Milky Way sign may be better treated not
with microsurgical lymphatic reconstruction but with com-
mphedema who underwent hysterectomy, bilateral iliac
earlier (clinical stage II). B, Lymphoscintigram shows
g with diminished number of lymph nodes in the left
am shows diffuse dermal backflow in the left leg.ity ly
years
left lepression and massage therapy.
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ICG fluorescence lymphography agreed well with actual clin-
ical diagnoses of secondary lymphedema determined by phys-
ical findings, medical history, and lymphoscintigram. In lym-
phoscintigraphy, qualitative interpretation of images has
resulted in excellent sensitivity (92 %) and specificity (100 %)
for the diagnosis of lymphedema.21 Further, larger-scale stud-
ies are needed to determine the sensitivity and specificity of
ICG fluorescence lymphography in diagnosing lymphedema
among patients with swollen legs. However, we consider that
this technique could replace lymphoscintigraphy for screening
lymphedema. Because ICG is already used in other clinical
tests with low cost, we believe that once the usefulness of the
ICG fluorescence lymphography for the identification of lym-
phatic disorder is confirmed, the Japanese government may
reimburse for ICG fluorescence lymphography.
In lymphoscintigraphy, quantitative analysis of lymph
transport was performed by obtaining dynamic images or
measuring the time it took for the injected dye to reach the
groin.22 Although the method was time-consuming and
difficult to reproduce, careful observation using the trans-
port index allowed quantitative analysis of lymph transport,
which could facilitate not only patient selection but also
follow-up observation in lymph vessel reconstruction.22-25
In this preliminary study, we have only performed qualita-
tive analysis. Quantitative analysis of lymph transport using
ICG fluorescence may also be possible with careful evalua-
tion of dynamic images of fluorescence.
CONCLUSION
This novel technique of ICG fluorescence lymphogra-
phy is safe and minimally invasive. The device is portable
and easy to use, and real-time fluorescent images can be
obtained. Panoramic images of the whole leg showed sev-
eral characteristic patterns of lymph drainage in patients
with secondary lymphedema. These findings suggested that
ICG fluorescence lymphography may be useful in daily
practice to differentiate lymphedema from edemas result-
ing from other causes.
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